Dr. Rabindra N Paul, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 10231 Old Ocean City Blvd, Suite 210, Berlin, MD 21811 Phone: 410-629-6888 Fax: 410-641-6874 |
News Archive
Scientists from the Florida campus of The Scripps Research Institute have uncovered the unique mechanism of a powerful natural product with wide-ranging antifungal, antibacterial, anti-malaria and anti-cancer effects.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved EDARBI for the treatment of hypertension, or high blood pressure, in adults.
Parkinson's disease (PD) is a devastating and incurable disease that causes abnormal poverty of movement, involuntary tremor, and lack of coordination. A technique called deep brain stimulation (DBS) is sometimes used to improve motor symptoms in patients with advanced disease. Now, a study published by Cell Press in the October 20 issue of the journal Neuron describes a new and more effective DBS paradigm that makes real-time adjustments in response to disease dynamics and progression and may be better for managing symptoms of advanced PD.
Novation today announced its dual-contract award in the Bone Densitometry category. Hologic, Inc. and Swissray International Inc. were both awarded agreements, replacing incumbent GE Healthcare in this category.
A study compared the top 10 common adverse events of COVID-19 vaccines and flu vaccine's adverse effects.
› Verified 3 days ago